Search

Your search keyword '"Havel, Jonathan"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Havel, Jonathan" Remove constraint Author: "Havel, Jonathan"
44 results on '"Havel, Jonathan"'

Search Results

1. Non-cell-autonomous cancer progression from chromosomal instability

2. Immunogenomics

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

4. Immunogenic neoantigens derived from gene fusions stimulate T cell responses

12. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

13. Protein–Protein Interactions

14. CANCER IMMUNOLOGY: Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

17. Commensal bacteria stimulate antitumor responses via T cell cross-reactivity

19. Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response

22. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

23. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

24. Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions

25. Abstract 2988: Immunogenomic analyses of tumor cells and microenvironment in patients with advanced melanoma before and after treatment with nivolumab

27. Abstract 632: Genome-scale neoantigen screening using ATLAS™ prioritizes candidate antigens for immunotherapy in a non-small cell lung cancer patient

28. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay

29. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one : National Harbor, MD, USA. 9-13 November 2016

30. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

37. Enabling systematic interrogation of protein--protein interactions in live cells with a versatile ultra-high-throughput biosensor platform.

41. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

42. Qa-1 b Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing.

43. Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform.

44. Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells.

Catalog

Books, media, physical & digital resources